Pharma & Biotech
Innovative pharma, specialty pharma, generics, biotech and advanced therapies.
Strategy & transformation consulting
Strategic clarity.Recommendations you can act on.Clear-eyed advice.
Axion Strategy advises health, life sciences and consumer care businesses on growth, commercial strategy, transformation and the practical use of AI. The work is grounded in market evidence, operating realities and clear trade-offs.
- Healthcare & life sciences depth
- Founder-led delivery
- Built for implementation
Sectors
Sector depth across health and consumer care
We focus on sectors where market structure, regulation, care pathways and buying dynamics materially shape the answer.
Medtech & Diagnostics
Medical devices, in-vitro diagnostics, imaging and laboratory equipment.
Care Providers
Clinics, diagnostic networks, health centres, laboratories and home-care operators.
Consumer Health & Nutrition
OTC products, food supplements, functional nutrition and wellbeing products.
Beauty & Personal Care
Cosmetics, dermocosmetics, skincare and personal-care brands.
Life Sciences Services
CROs, CDMOs, ingredients, packaging, distribution and specialised suppliers.
Healthtech & Data
Healthcare software, data platforms, AI solutions and workflow technologies.
Why Axion
A senior, evidence-led way of working
Sector depth
Sector context is built into the analysis: market structure, clinical pathways, regulation, economics and buying behaviour.
Evidence-led judgement
We separate facts, assumptions and judgement, then make the trade-offs explicit.
Implementation realism
Recommendations are tested against the client's resources, capabilities and operating constraints.
Founder-led delivery
The person who scopes the work stays directly involved in the analysis, recommendation and client dialogue.
Capabilities
Where we help
Focused strategy and transformation work organised around four distinct business questions.
Growth & Portfolio Strategy
- Market assessment
- Growth strategy
- Portfolio prioritisation
- Market entry
- Commercial due diligence
- Investment thesis
Go-to-Market & Commercial Performance
- Customer segmentation
- Value proposition
- Channel strategy
- Commercial model
- Key-account strategy
- Sales effectiveness
Operating Model & Transformation
- Target operating model
- Organisation design
- Process redesign
- Performance management
- Transformation roadmap
- Implementation support
AI Strategy, Automation & Adoption
- AI opportunity assessment
- Use-case prioritisation
- Data and process readiness
- Business cases and roadmap
- Agents and workflow automation
- Deployment and adoption
How we work
From business question to executable plan
- 01
Frame the question
Define the decision, the scope, the constraints and the criteria that will determine a good answer.
- 02
Build the evidence
Combine market insight, internal data and operational input to test the key hypotheses.
- 03
Make the choice
Compare the options, make the trade-offs explicit and recommend a clear course of action.
- 04
Mobilise delivery
Translate the decision into priorities, owners, milestones and an implementation roadmap.
Outputs
Decision-ready outputs
We keep deliverables concise, but not superficial. The aim is to make the analysis auditable, the recommendation clear and the next steps executable.
- Executive decision deck
- Analytical model
- Prioritised roadmap
- Implementation plan
Selected experience
Relevant work in health and life sciences
Selected engagements completed by the founder before Axion Strategy. Client names are withheld.
Commercial due diligence
Assessing a European nutraceutical and health-product CDMO as a potential add-on acquisition for a private equity-backed platform.
Scope
Market sizing, segment attractiveness, customer and competitor analysis, growth thesis and assessment of the build-up rationale.
Market assessment & go-to-market
Assessing the opportunity for molecular diagnostic assays in autoimmune disease across six priority markets.
Scope
Country-level market sizing, testing pathways, stakeholder mapping, portfolio priorities and go-to-market options for Algeria, Poland, India, the UAE, Saudi Arabia and Türkiye.
European portfolio growth
Assessing growth opportunities for a diagnostics portfolio across selected European markets.
Scope
Market sizing, testing pathways, competitive dynamics, adoption barriers and country prioritisation for commercial expansion.
Key-account strategy
Designing a key-account strategy for an infectious-disease diagnostics business across priority African markets.
Scope
Segmentation of public and private accounts, mapping of decision-makers and procurement routes, and definition of account-level priorities and engagement plans.
Market prioritisation
Identifying high-potential European markets for medical gases used in emergency transport and ambulance services.
Scope
A country-level opportunity screen combining ambulance fleet structure, care-delivery models, regulation, procurement and addressable demand.
Founder
Founder-led by Yanis Boudjemai
Yanis Boudjemai is a strategy and AI consultant with experience in growth strategy, commercial due diligence, go-to-market and transformation. His prior consulting experience includes Bain & Company, Advancy and Advention Business Partners, with a focus on healthcare, diagnostics, life sciences and specialised industrial markets.
Founder-led delivery
The person who scopes the engagement remains directly involved throughout the work.
Independent judgement
The recommendation follows the evidence, not the expected answer.
Focused engagements
Each project is built around a defined business question, a clear scope and a usable output.
Have a strategic decision to make?
Discuss the question, the available evidence and the practical options with Axion Strategy.
Discuss a projectcontact@askaxion.com